Facile preparation of near-infrared fluorescence and magnetic resonance dual-modality imaging probes based on mesoporous organosilica nanoparticles

Tumor targeting near-infrared fluorescence and magnetic resonance dual-modality imaging probes are prepared by connecting functional molecules on thioether-bridged mesoporous organosilica nanoparticles via click reaction. [Display omitted] In this work, near-infrared fluorescence (NIRF) and magnetic...

Full description

Saved in:
Bibliographic Details
Published inJournal of colloid and interface science Vol. 539; pp. 277 - 286
Main Authors Li, Yanjiao, Guo, Wenwen, Su, Xiaodan, Lu, Nan, Wu, Guangyao, Ou-Yang, Lin, Dang, Meng, Tao, Jun, Teng, Zhaogang
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 15.03.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Tumor targeting near-infrared fluorescence and magnetic resonance dual-modality imaging probes are prepared by connecting functional molecules on thioether-bridged mesoporous organosilica nanoparticles via click reaction. [Display omitted] In this work, near-infrared fluorescence (NIRF) and magnetic resonance (MR) dual-modality imaging probes are prepared by conjugating maleimide derivative cyanine dye (Mal-Cy5.5), gadolinium‐diethylenetriamine pentaacetic acid (Gd-DTPA), and RGD peptide (Mal-PEG2-RGD) on thioether-bridged mesoporous organosilica nanoparticles (MONs) via click reaction. Fourier transform infrared (FT-IR) spectra, zeta potentials, UV–vis spectra, and energy dispersive X-ray (EDX) spectrum confirm the successful modifications of the functional molecules on the MONs. The prepared MON-Gd-Cy5.5-RGD probes shows excellent NIRF and MR imaging properties, and the relaxivity rate (r1) is measured up to 2.85 mM−1 s −1. In addition, the MON-Gd-Cy5.5-RGD probes show excellent in vitro and in vivo biocompatibility. Confocal laser scanning microscopy and flow cytometry demonstrate that the MON-Gd-Cy5.5-RGD can efficiently target to MDA-MB-231 tumor cells. Additionally, ex vivo NIFR and in vivo MR imaging demonstrate that the MON-Gd-Cy5.5-RGD probes can accumulate in tumor and improve the signals of tumor.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-9797
1095-7103
DOI:10.1016/j.jcis.2018.12.067